雷氏品牌怎么样 申请店铺

我要投票 雷氏在珍珠粉行业中的票数:230 更新时间:2025-04-02
雷氏是哪个国家的品牌?「雷氏」是 上海雷允上药业有限公司 旗下著名品牌。该品牌发源于上海,由创始人苏俊英在1998-11-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力雷氏品牌出海!通过在本页面挂载雷氏品牌的产品链接和联系邮箱,可以提高雷氏产品曝光!跨境电商爆单神器,目前只要100元/年哦~

雷氏怎么样

百年老字号雷允上药店始建于苏州,发迹于上海,迄今已有近三百年历史。公元1734年(清雍正十二年)创始于苏州;1860年(清咸丰十年)设“申号”于上海新北门外,1934年设“北号”于河南北路天后宫桥(今河南路桥)北堍,1937年又设北号支店于静安寺路(今南京西路)。由于药店规模较大,资产雄厚,影响面广,早年就被国药同业公认为上海中药店“四大户"之一。中国改革开放以来,经资产重组,工商联手,今日上海雷允上药业雄风再现,成为中国中药行业的强者。雷允上药业历史渊源>>

上海雷允上药业有限公司是上药集团上海市药材有限公司为投资主体成立的集农工商、科工贸、产学研于一体的大型中药企业,历年被认定为上海市高新技术企业、上海市文明单位,是上海市第一批知识产权示范企业,旗下“雷氏”品牌被认定为中国驰名商标,并以20.8亿的品牌价值荣获中国500最具价值品牌称号。近年来,公司及其品牌先后获得中国百年中药老字号企业、最具价值的上海老商标、上海市出口名牌、上海市装备制造业与高新技术产业自主创新品牌、上海现代服务业百强等荣誉称号。

公司拥有严格的质量保证体系。从中药产业链源头GAP规范标准入手,严格原药材采购控制。拥有国家GMP规范要求的中药产业化制造基地,能生产20多个剂型500多个品种。拥有包括中药材、中成药、保健品和名贵参茸等在内的强大的专业营销网络,辐射全国,足迹遍及东南亚、北美、欧洲等地。雷允上连锁多年被评为最具影响力特许品牌。六神丸、雷氏珍菊降压片、雷氏炮天红酒等产品历年被评为上海市名牌产品,在海内外均享有较高的声誉。多年坚持开展社区健康服务,2006年赢得了“全国卫生进社区——相约健康社区行”社会公益奖。

公司传承“至诚至信,关爱生命”的企业追求,竭尽所能地致力于服务社会、造福人类的伟大事业,为弘扬祖国优秀中医药文化,为人类的健康贡献力量。

The century old drugstore under leiyunshang pharmaceutical was founded in Suzhou and started in Shanghai. It has a history of nearly 300 years. It was founded in Suzhou in 1734 (the 12th year of Yongzheng reign in the Qing Dynasty); in 1860 (the 10th year of Xianfeng reign in the Qing Dynasty), it was set up outside the new North Gate of Shanghai; in 1934, it was set up in the north end of hougongqiao (now Henan Road bridge), North Henan Road; in 1937, it was set up in Jingansi Road (now Nanjing West Road). Due to the large scale, strong assets and wide influence of drugstores, they have been recognized as one of the "four big families" of Shanghai Traditional Chinese medicine stores by the pharmaceutical industry in the early years. Since China's reform and opening up, through asset restructuring and joint efforts of industry and commerce, the pharmaceutical industry of Shanghai leiyunshang Pharmaceutical Co., Ltd. has reappeared today, becoming a strong player in the Chinese traditional medicine industry. The history of pharmaceutical industry under leiyunshang pharmaceutical & gt; & gt; Shanghai leiyunshang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine enterprise established by Shanghai Pharmaceutical Group Co., Ltd. as the main investor, integrating agriculture, industry and commerce, science, industry and trade, production, learning and research. It has been recognized as a high-tech enterprise in Shanghai and a civilized unit in Shanghai. It is the first batch of intellectual property demonstration enterprises in Shanghai. Its "Leishi" brand is recognized as a well-known trademark in China Won the title of China's 500 most valuable brand with a brand value of 2.08 billion. In recent years, the company and its brand have successively won the honorary titles of China's century old brand enterprise of traditional Chinese medicine, the most valuable old trademark of Shanghai, Shanghai Export famous brand, independent innovation brand of Shanghai equipment manufacturing industry and high-tech industry, and top 100 modern service industry of Shanghai. The company has a strict quality assurance system. Starting from the gap standard of the source of traditional Chinese medicine industry chain, strictly control the purchase of original Chinese medicine. It has the industrialization manufacturing base of traditional Chinese medicine required by the national GMP standard, and can produce more than 20 dosage forms and more than 500 varieties. It has a strong professional marketing network including traditional Chinese medicine, Chinese patent medicine, health care products and rare ginseng antler, covering the whole country, covering Southeast Asia, North America, Europe and other places. Leiyunshang chain has been rated as the most influential franchise brand for many years. Liushenwan, Zhenju hypotensive tablet and Baotian red wine have been rated as famous brand products in Shanghai over the years, enjoying a high reputation at home and abroad. In 2006, it won the social public welfare award of "national health into the community - meeting healthy communities". The company inherits the enterprise pursuit of "sincere and trustworthy, caring for life", devotes itself to the great cause of serving the society and benefiting the human as much as possible, promotes the excellent traditional Chinese medicine culture of the motherland and contributes to the health of human beings.

本文链接: https://brand.waitui.com/942bfee42.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

加力扩围发力显效,“两新”政策激发消费活力

4月1日,国家发展改革委消息显示,今年前两个月,“两新”政策进一步发力显效,带动设备工器具购置投资同比增长18%,社会消费品零售总额同比增长4%,继续发挥扩消费、稳投资、促转型、惠民生的重要作用。国家发展改革委指出,“两新”政策有效激发了消费活力。今年超长期特别国债支持消费品以旧换新资金规模增加至3000亿元,相较去年的资金规模翻了一番。首批810亿元资金于1月6日第一时间下达,延续2024年工作基础,扩围支持手机、平板、智能手表手环等数码产品购新。(证券时报)

2小时前

2024年中国为欧盟汽车进口最大来源国

4月1日,欧盟发布2024年欧盟汽车行业贸易数据,中国以127亿欧元进口额成为欧盟汽车进口最大来源国,欧方称,2019-2024五年间,欧盟自中国进口汽车增幅高达1591.3%;尽管如此,2024年欧盟对华汽车贸易保持顺差,对华出口高达145亿欧元。2024年,欧盟共出口汽车540万辆,进口汽车400万辆。与2019年相比,出口数量下降了13.2%,进口数量则减少了3.0%。(界面)

2小时前

业绩承诺仅完成6.7%,三鑫医疗高溢价投资面临追偿难

三年累计不低于4200万元的业绩承诺,实际完成280.42万元,完成率仅为6.7%,业绩承诺方暂时无法拿出充足的资金进行股份回购补偿。近日,三鑫医疗一则关于参股公司业绩承诺实现情况专项说明的公告引发众多投资者关注。有受访投行人士分析,高业绩承诺对应的一定是高估值,高估值就意味着高风险,这也提醒上市公司在投资时要紧紧围绕自身战略进行布局,真正做好风险控制。(上证报)

2小时前

全球风险资产震荡,市场静待关税靴子落地

美国即将于4月2日启动对等关税,引发市场连锁反应。美股三大指数上周集体下挫,亚太市场同步承压,避险资金则推动黄金现货价格触及3149.03美元/盎司的历史高位。随着政策实施时点临近,市场对美国经济政策框架的能见度逐步提升。部分机构表示,政策的可预测性上升,积极信号正在酝酿;也有机构对风险资产的表现感到担忧。尽管短期波动性骤增,但市场普遍认为,4月2日将为接下来几个月的金融市场走向定下基调。(中证网)

2小时前

中信建投:电解铝强调清洁能源代替,绿证市场有望加速成长

36氪获悉,中信建投证券研报显示,近期,工业和信息化部等十部门发布关于印发《铝产业高质量发展实施方案(2025—2027年)》。具体来看,《方案》鼓励企业参与光伏、风电等可再生能源和氢能、储能系统开发建设。推进氢氧化铝焙烧、铝用阳极焙烧环节实施清洁能源替代。在我国能耗双控转型的背景下,高耗能企业的清洁用能替代需求有望持续增长,有助于绿电、绿证市场的加速发展,有利于风光项目环境价值的兑现。

2小时前

本页详细列出关于雷氏的品牌信息,含品牌所属公司介绍,雷氏所处行业的品牌地位及优势。
咨询